RTE market is booming
Ready‑to‑eat (RTE) foods are exploding — the market is forecast to jump from $196.7B in 2025 to $275.4B in 2026, driven by demand for convenient, plant‑forward options (openpr.com). Trend reports also flag ‘snackification,’ nostalgic classics made healthier, and GLP‑1‑friendly items as major drivers of innovation in 2026 (foodnavigator.com).
Analyst estimates for the RTE market diverge sharply: Mordor Intelligence lists the sector at about $422.62 billion for 2026 with a 6.12% CAGR to 2031, Fortune Business Insights projects roughly $447.62 billion in 2026 and growth to $706.78 billion by 2034 (CAGR 5.88%), while IMARC’s forecast shows a slower multi-year expansion (different base numbers reflect varying methodologies). (mordorintelligence.com)) Major CPG and food companies dominate supply and deal activity — Mordor names Conagra, Nestlé, General Mills, Tyson and Mars as leading players in RTE; at the same time, 2026 saw consolidation in the plant‑forward DTC space with Splendid Spoon’s acquisition of Mosaic Foods (deal announced in January 2026), a tie-up the firms say combines >$190 million in cumulative revenue and a combined catalogue of some 200+ SKUs. (mordorintelligence.com)) GLP‑1–targeted positioning has moved from niche to mainstream: Conagra introduced a GLP‑1–oriented “On Track” badge on Healthy Choice items in 2025, major news agencies report supermarket shelves now carry unregulated “GLP‑1 friendly” labels, and national chains including Chipotle and Shake Shack have launched high‑protein, GLP‑1–supportive menus this year. (conagrabrands.com)) Product format shifts are reshaping RTE innovation — “snackification” (more meal‑like snacks and mini‑meals) is cited by industry trackers and FMCG research as a 2026 growth vector, while brands are reworking nostalgic flavors into lower‑calorie or higher‑protein formats to capture demand for comfort plus better‑for‑you credentials. (fmcggurus.com)) Plant‑forward RTE subsegments are posting measurable gains: U.S. plant‑based ready meals were estimated at about $0.75 billion in 2025 with forecasts to roughly $1.85 billion by 2035 (near‑9% CAGR), underpinning investor interest and recent M&A aimed at scaling manufacturing and retail distribution for healthier convenience offerings. (futuremarketinsights.com))
